ANIP

ANI Pharmaceuticals Inc.

Price

$78.02

return (12m)

-13.43%

p/e

14.65

p/bv

2.66

DIVIDEND YIELD

0.00%

ANIP price

ANI Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ANIP

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.19%

3 months

-5.74%

1 year

-13.43%

2 years

27.42%

5 years

165.46%

10 years

15.71%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ANIP

Valuation

P/E

14.65

Sector -2.19

Industry 1.21

P/BV

2.66

Sector 2.22

Industry 2.11

P/Revenue (PSR)

1.62

Sector 2.01

Industry 0.78

EV/EBITDA

29.82

Sector -17.81

Industry -25.30

EV/EBIT

44.21

Sector -26.72

Industry -18.04

P/EBITDA

6.48

Sector 0.36

Industry 0.18

P/EBIT

9.97

Sector -3.34

Industry 1.26

P/Total Assets

1.06

Sector 1.23

Industry 0.86

P/Net Current Assets

-22.21

Sector -27.35

Industry -12.37

P/Working Capital

2.93

Sector -4.54

Industry -49.48

EPS

5.16

Sector -0.87

Industry -0.55

BVPS

28.44

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

60.40%

Sector 43.36%

Industry 31.53%

EBITDA Margin

22.69%

Sector -323.65%

Industry -73.39%

EBIT Margin

15.31%

Sector -194.57%

Industry -11.94%

Operating Margin

13.34%

Sector -24.37%

Industry -9.87%

Net Profit Margins

11.07%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.18

Sector 0.12

Industry 0.22

Profitability

ROE

18.14%

Sector -33.82%

Industry -37.56%

ROA

7.25%

Sector -29.63%

Industry -17.56%

ROIC

11.40%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

2.91

Sector 1.84

Industry 1.14

Net Debt / EBITDA

3.53

Sector -1.47

Industry -31.86

Net Debt / EBIT

5.24

Sector -1.32

Industry 2.06

Net Debt / Equity

0.36

Sector -0.35

Industry 0.14

Gross Debt / Equity

0.99

Sector 0.14

Industry 0.51

Equity/Assets

0.40

Sector 0.42

Industry 0.25

Liabilities/Assets

0.60

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

35.26%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF ANI Pharmaceuticals ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$78.02

Fair Value

$57.46

Upside Return potential.

-26.35%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals ANIP

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ANIP ANI Pharmaceuticals Inc.	$78.02	-13.43%	0.00%	14.65	2.66	18.14%	11.07%
LLY Eli Lilly and Compay	$1,280.34	83.05%	0.54%	39.62	31.24	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$397.72	-17.36%	0.00%	45.09	7.73	17.15%	28.45%
SNY Sanofi	$45.83	-4.42%	4.04%	7.10	1.31	18.43%	13.81%
NVS Novartis AG	$160.31	31.78%	2.05%	22.57	6.87	30.41%	22.50%
TMO Thermo Fisher Scientific Inc.	$613.54	26.39%	0.30%	31.58	4.17	13.19%	15.04%
ABT Abbott Laboratories	$114.43	-11.62%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$94.13	4.71%	3.10%	24.50	2.35	9.59%	13.20%
GSK GlaxoSmithKline PLC	$52.88	41.51%	3.59%	15.15	4.28	28.24%	14.54%
CVS CVS Health Corporation	$93.65	37.68%	2.73%	25.48	1.56	6.12%	1.18%
BSX Boston Scientific Corp.	$52.01	-49.87%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.97	-25.21%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$562.20	-11.86%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$230.65	-18.34%	1.07%	21.40	4.95	23.13%	26.94%
DHR Danaher Corporation	$211.50	0.79%	0.71%	35.81	2.73	7.61%	15.95%
HCA HCA Healthcare Inc.	$407.05	4.09%	0.74%	13.12	-27.97	-213.15%	8.77%
COHR Coherent Inc.	$287.47	217.68%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.62	4.58%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$339.98	-9.77%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$15.04	5.14%	0.00%	11.54	1.42	12.32%	20.69%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ANIP Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT ANI Pharmaceuticals

ANI Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (1 people)

United States

25 years

Founded: 2001

1999

Time since IPO - 27 years

369

Employees

ANI Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.59 billion, with shareholders equity totaling $597.21 million.

The company employs approximately 369 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, ANI Pharmaceuticals Inc. reported $978.37 million in revenue, generating net income of $108.31 million.

Key financial metrics include a P/E ratio of 14.65, a price-to-book (P/B) ratio of 2.66, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ANIP.

Market cap

$1.59 billion

Net worth

$597.21 million

$597,210,000.00

Assets

$1.49 billion

$1,494,110,000.00

Total Shares Outstanding

21.00 million

21,000,000

Average Daily Trading Volume

$338.26 Thousand

$338,256.44

Sector

Health

Industry

Pharmaceutical Products

ANIP

ANIP revenue and profits

Financial Results ANIP

DRAG THE FRAME TO SEE MORE DATA

ANIP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.65 36,41% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$277.45 --6,37% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.69 120,03% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$378.02 32,24% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.83 --5,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,280.34 81,92% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.05 --0,11% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$160.31 28,43% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87